GNI Group Ltd
TSE:2160

Watchlist Manager
GNI Group Ltd Logo
GNI Group Ltd
TSE:2160
Watchlist
Price: 2 480 JPY 8.3%
Market Cap: 137.9B JPY

Operating Margin
GNI Group Ltd

-5.6%
Current
16%
Average
-4.3%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-5.6%
=
Operating Profit
-1.4B
/
Revenue
25.8B

Operating Margin Across Competitors

No Stocks Found

GNI Group Ltd
Glance View

Market Cap
137.9B JPY
Industry
Biotechnology

GNI Group Ltd. engages in the development, research, manufacture, and sale of pharmaceutical drugs and traditional Chinese medicines. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 629 full-time employees. The company went IPO on 2007-08-31. The firm is engaged in the development of therapeutic agents for diseases that have many sufferers in Asian countries such as Japan and China, as well as clinical trial and bio-verification test businesses. The company is engaged in research and development of therapeutic agents, including F647 for radiation pneumonia (RP) and idiopathic pulmonary fibrosis (IPF), F351 for liver fibrosis (cirrhosis) and F573 for acute hepatic insufficiency and acute chronic liver failure (ACLF).

Intrinsic Value
4 937.89 JPY
Undervaluation 50%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-5.6%
=
Operating Profit
-1.4B
/
Revenue
25.8B
What is the Operating Margin of GNI Group Ltd?

Based on GNI Group Ltd's most recent financial statements, the company has Operating Margin of -5.6%.

Back to Top